322 related articles for article (PubMed ID: 31185755)
1. Therapeutic effects of isoflavone-aglycone fraction from soybean (
Alivandi Farkhad S; Khazali H
Gynecol Endocrinol; 2019 Dec; 35(12):1078-1083. PubMed ID: 31185755
[TBL] [Abstract][Full Text] [Related]
2. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism.
Rajan RK; M SS; Balaji B
Pharm Biol; 2017 Dec; 55(1):242-251. PubMed ID: 27927075
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potentials of the natural plant flavonoid apigenin in polycystic ovary syndrome in rat model: via modulation of pro-inflammatory cytokines and antioxidant activity.
Darabi P; Khazali H; Mehrabani Natanzi M
Gynecol Endocrinol; 2020 Jul; 36(7):582-587. PubMed ID: 31888395
[TBL] [Abstract][Full Text] [Related]
4. Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF- κB signaling pathway.
Ma X; Li X; Ma L; Chen Y; He S
Bioengineered; 2021 Dec; 12(1):7215-7223. PubMed ID: 34546841
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Soy Isoflavones on Metabolic Status of Patients With Polycystic Ovary Syndrome.
Jamilian M; Asemi Z
J Clin Endocrinol Metab; 2016 Sep; 101(9):3386-94. PubMed ID: 27490918
[TBL] [Abstract][Full Text] [Related]
6. Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats.
Mohammed S; Sundaram V; Zyuzikov N
J Ovarian Res; 2021 Feb; 14(1):26. PubMed ID: 33546719
[TBL] [Abstract][Full Text] [Related]
7. L-Carnitine improves endocrine function and folliculogenesis by reducing inflammation, oxidative stress and apoptosis in mice following induction of polycystic ovary syndrome.
Kalhori Z; Mehranjani MS; Azadbakht M; Shariatzadeh MA
Reprod Fertil Dev; 2019 Jan; 31(2):282-293. PubMed ID: 31039949
[TBL] [Abstract][Full Text] [Related]
8. Novel promising reproductive and metabolic effects of Cicer arietinum L. extract on letrozole induced polycystic ovary syndrome in rat model.
Ali SE; El Badawy SA; Elmosalamy SH; Emam SR; Azouz AA; Galal MK; Abd-Elsalam RM; Issa MY; Hassan BB
J Ethnopharmacol; 2021 Oct; 278():114318. PubMed ID: 34111539
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone and dimethylsulfoxide effect on glucose metabolism and oxidative stress markers in polycystic ovarian syndrome rat model.
Dăneasă A; Cucolaș C; Furcea M; Bolfa P; Dudea S; Olteanu D; Alupei MC; Mureșan A; Filip GA
Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):154-62. PubMed ID: 24643692
[TBL] [Abstract][Full Text] [Related]
10. The effect of ellagic acid on sex hormones and miRNA-21 expression in rats with polycystic ovary syndrome.
Khoshvaghti A; Rahbari R
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4263-4273. PubMed ID: 38078918
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of glycemic and oxidative/antioxidative status in the estradiol valerate-induced PCOS model of rats.
Dikmen A; Ergenoglu AM; Yeniel AO; Dilsiz OY; Ercan G; Yilmaz H
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):55-9. PubMed ID: 22071112
[TBL] [Abstract][Full Text] [Related]
12. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.
Furat Rencber S; Kurnaz Ozbek S; Eraldemır C; Sezer Z; Kum T; Ceylan S; Guzel E
J Ovarian Res; 2018 Jun; 11(1):55. PubMed ID: 29958542
[TBL] [Abstract][Full Text] [Related]
13. Letrozole vs estradiol valerate induced PCOS in rats: glycemic, oxidative and inflammatory status assessment.
Dăneasă A; Cucolaş C; Lenghel LM; Olteanu D; Orăsan R; Filip GA
Reproduction; 2016 Apr; 151(4):401-9. PubMed ID: 26792865
[TBL] [Abstract][Full Text] [Related]
14. A combination of spearmint and flaxseed extract improved endocrine and histomorphology of ovary in experimental PCOS.
Mehraban M; Jelodar G; Rahmanifar F
J Ovarian Res; 2020 Mar; 13(1):32. PubMed ID: 32197626
[TBL] [Abstract][Full Text] [Related]
15. HemoHIM improves ovarian morphology and decreases expression of nerve growth factor in rats with steroid-induced polycystic ovaries.
Kim SH; Lee HJ; Kim JS; Moon C; Kim JC; Bae CS; Park HR; Jung U; Jo SK
J Med Food; 2009 Dec; 12(6):1348-52. PubMed ID: 20041792
[TBL] [Abstract][Full Text] [Related]
16. Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress.
Huang Y; Zhang X
Am J Physiol Endocrinol Metab; 2021 Jun; 320(6):E1085-E1092. PubMed ID: 33900851
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of oral and local intraovarian administration of metformin and nanoparticles (NPs11) in alleviating testosterone-induced polycystic ovary syndrome in rats.
Al-Thamarani S; Gad S; Abdel Fattah IO; Hammadi SH; Hammady TM
Tissue Cell; 2024 Jun; 88():102394. PubMed ID: 38663112
[TBL] [Abstract][Full Text] [Related]
18. Effects of jnk inhibitor on inflammation and fibrosis in the ovary tissue of a rat model of polycystic ovary syndrome.
Bulut G; Kurdoglu Z; Dönmez YB; Kurdoglu M; Erten R
Int J Clin Exp Pathol; 2015; 8(8):8774-85. PubMed ID: 26464620
[TBL] [Abstract][Full Text] [Related]
19. Chronic niacin administration ameliorates ovulation, histological changes in the ovary and adiponectin concentrations in a rat model of polycystic ovary syndrome.
Asadi N; Izadi M; Aflatounian A; Esmaeili-Dehaj M; Rezvani ME; Hafizi Z
Reprod Fertil Dev; 2021 May; 33(7):447-454. PubMed ID: 33751926
[TBL] [Abstract][Full Text] [Related]
20. The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats.
Rababa'h AM; Matani BR; Ababneh MA
Life Sci; 2020 Nov; 261():118353. PubMed ID: 32877649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
